NZBIO - News

02 Feb 2012 - Biomatters’ US focus drives over 50% sales increase during 2011 Increasing uptake of Biomatters’ flagship product, Geneious, by customers worldwide has driven a more than 50% increase in Biomatters’ sales revenue for 2011

01 Feb 2012 - New Zealand diagnostics company to hire 100 in PA New Zealand's Pacific Edge Diagnostics is taking its diagnostic expertise abroad, opening its first U.S. franchise in Hershey, PA.

31 Jan 2012 - KiwiNet launches innovation database to promote new technologies and research internationally The Kiwi Innovation Network (KiwiNet) launched its online innovation database today, enabling businesses, entrepreneurs and investors worldwide to view a diverse range of technologies and expertise in New Zealand’s research organisations.

26 Jan 2012 - ZYGEM TO PROVIDE ITS UNIQUE DNA AND RNA EXTRACTION TECHNOLOGY TO MIDDLE EAST BIOMEDICAL INNOVATOR SAUDI DIAGNOSTICS LTD. ZyGEM Corp. Ltd., a developer and marketer of innovative products for the analysis of DNA and other nucleic acids, today announced that it has signed an OEM agreement with Saudi Diagnostics Limited (SDL) for ZyGEM’s DNA and RNA extraction kits.

25 Jan 2012 - Biofuels firm may list on NZX The pioneering biofuels developer LanzaTech is considering listing on the New Zealand stock exchange, after it announced it had secured more than US$50 million in new funding from international and local investors.

24 Jan 2012 - NZ-developed drug breaks into US$400 million market New Zealand’s Douglas Pharmaceuticals announced today it had gained Food and Drug Administration (FDA) approval to sell its NZ-developed acne medication, isotretinoin, in the United States.

23 Jan 2012 - LanzaTech Closes US $55.8 Million Series C Round LanzaTech, a producer of low-carbon fuels and chemicals from waste gases, has closed its Series C round with new investment totaling US $55.8 million led by the Malaysian Life Sciences Capital Fund.

17 Jan 2012 - Douglas Pharmaceuticals expanding exports The global reach of Douglas Pharmaceuticals is set to expand further, with product registrations under way for it to start exporting to new territories.

16 Jan 2012 - Health firms feature as NZ International Business Awards finalists Life science and healthcare companies are among the 27 finalists in the 2012 New Zealand International Business Awards, which recognise the myriad of ways companies now do business globally.

15 Jan 2012 - New Zealand Biotech Company Argenta Wins $100,000 Cisco Makeover CompetitionNew Zealand Biotech Company Argenta Wins $100,000 Cisco Makeover Competition Cisco has today announced Kiwi biotech company Argenta as the winner of the 2011 Cisco New Zealand Communications Makeover Competition. Selected from 125 entries, Argenta will receive NZ$100,000 worth of technology and installed services sponsored by Cisco and Orcon.

12 Jan 2012 - Genesis Research plans ‘reverse takeover’ with Mariposa Genesis Research and Development plans to merge with Mariposa Health, an unlisted Australia medical researcher that would own 80 percent of the enlarged company and provide development projects for treatment of lung disease and the Golden staph bacteria.

04 Jan 2012 - Range Fuels Sells Government-Backed Biofuel Plant to LanzaTech Range Fuels Inc. a closely held U.S. cellulosic ethanol company, sold its only factory to LanzaTech NZ Ltd.

28 Dec 2011 - LCT appoints Chief Executive Living Cell Technologies Limited has appointed Dr Andrea Grant as Chief Executive Officer.

20 Dec 2011 - New Zealand ‘ideally positioned’ for food science leadership New Zealand is uniquely positioned to show the world the economic and lifestyle benefits of a nutritional pathway to disease prevention and good health, says Lincoln University’s first Professor of Food Science, Charles Brennan who has come to the position from a professorship in Food Chemistry and Nutrition in the United Kingdom.

20 Dec 2011 - NZBIO 2010 Bioscience Industry Report: Take a bow biosciences The 2010 Bioscience Industry Report comes with some pretty encouraging news for those making clever use of biology and brains

NZBIO PARTNERS

News

Archives